The short version of GLP-1 receptor fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-07-09 and is reviewed periodically as new material appears.
At the receptor level, the compound binds both GIP and GLP-1 receptors and triggers downstream signalling that raises cyclic AMP in target cells. GLP-1 receptor activation is associated with glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. GIP receptor activation contributes effects that are less completely characterised, and how much each receptor adds to the overall clinical response is still an open question. The two pathways appear to interact in a complementary rather than a purely additive way.
An extended fatty diacid moiety promotes binding to serum albumin, which slows renal clearance and extends the circulating half-life to roughly five days. That property supports once-weekly administration and largely explains the dosing interval described in clinical reports. Published data come mainly from large randomised programmes that evaluated glycaemic control and body weight over periods of many months. Long-term outcomes beyond those trial windows, including what happens after treatment stops, remain an active area of investigation.
Tirzepatide is a synthetic peptide built from thirty-nine amino acids. Its sequence is derived from native glucose-dependent insulinotropic polypeptide, or GIP, with several non-natural residues and a fatty diacid side chain attached through a linker. The molecule behaves as a dual agonist at two incretin receptors, GIP and GLP-1, instead of targeting a single receptor. This dual engagement separates it from earlier single-receptor incretin compounds and underpins most of its reported pharmacological activity.
Clinical research programs have evaluated tirzepatide in adults with type 2 diabetes and in adults with obesity or excess weight. Trials generally reported reductions in glycated hemoglobin and body weight across treatment periods of several months. Since these studies enrolled defined populations under controlled conditions, the findings describe group averages rather than individual outcomes. Open questions include the durability of effects after treatment stops, variation among subgroups, and the long-term consequences of sustained dual receptor stimulation. Published trial summaries should be consulted for exact measurements rather than secondary accounts.
Tirzepatide is a synthetic peptide built from 39 amino acid residues. Its backbone derives from the native glucose-dependent insulinotropic polypeptide sequence, altered at several positions to resist enzymatic cleavage. A fatty diacid group attached through a linker extends plasma residence time by promoting reversible binding to serum albumin. The molecule carries a net negative charge near physiological pH and has a reported molecular weight close to 4813 daltons. These features separate it from shorter incretin analogs and account for its prolonged dosing interval.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | Free base form |
| Molecular mass | Approximately 4813 Da | Calculated from the sequence |
| Amino acid residues | 39 | GIP-derived backbone |
| Receptor targets | GIP and GLP-1 | Dual agonist |
| Circulating half-life | About 5 days | Supports weekly administration |
Storage recommendations for tirzepatide generally specify refrigeration at 2–8 °C to maintain stability. The peptide should be protected from light and kept in its original packaging to prevent aggregation or adsorption. Freezing is not recommended because freeze-thaw cycles can cause aggregation or precipitation. Once dispensed, storage conditions and in-use periods follow product-specific labeling, which may allow room temperature storage for a limited time.
Degradation pathways for tirzepatide include deamidation, oxidation, and aggregation, which are common for therapeutic peptides. These processes can be monitored by size-exclusion chromatography (SEC) for aggregates and ion-exchange chromatography for charge variants. Forced degradation studies under acidic, basic, oxidative, and thermal stress help identify potential impurities. The exact stability profile depends on formulation, concentration, and container-closure system.
Regulatory and quality discussions place the peptide within established guidance for synthetic peptides and biologics. Forced degradation studies, in which samples are exposed to heat, acid, base, peroxide, and light, identify likely degradation products and validate the selectivity of analytical methods. Reference standards allow comparison across laboratories and production batches. Purity specifications reported in the literature usually combine chromatographic purity with mass confirmation. Which impurity thresholds are meaningful for long-term behavior is still debated, and no single universal specification has been adopted across all jurisdictions.
Routine characterization of the peptide relies on reversed-phase high-performance liquid chromatography for purity assessment, usually with ultraviolet detection near 214 nanometers. Intact mass measurement by liquid chromatography coupled to mass spectrometry confirms molecular identity against a theoretical value. Sequence-level confirmation uses enzymatic digestion followed by tandem mass spectrometry, an approach known as peptide mapping. Amino acid analysis gives an independent check on composition. Circular dichroism spectra are used to estimate helical content in aqueous buffer.
Both receptors are class B G protein-coupled receptors that signal largely through Gs-mediated cyclic AMP production. Activation within pancreatic islets increases glucose-dependent insulin secretion and suppresses glucagon release when glucose is elevated. Outside the pancreas, signaling in the central nervous system and gut appears to influence appetite and gastric emptying. The relative contribution of each receptor to observed clinical effects remains under investigation, and the two pathways are not simply additive in practice.
Reported outcomes in large trials include dose-dependent weight reduction and improvements in glycemic markers over periods ranging from several months to more than a year. Whether the compound alters long-term cardiovascular or renal outcomes is being examined in dedicated outcome studies, so those questions remain open. Labeling describes gastrointestinal effects such as nausea and diarrhea, which tend to appear during dose escalation. Discontinuation rates and the durability of effects after treatment stops vary across study populations and are still debated.
Tirzepatide is a synthetic peptide composed of 39 amino acids. It acts as a dual agonist at two incretin receptors, the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. The molecule was designed by modifying the native sequence of glucose-dependent insulinotropic polypeptide to improve metabolic stability and extend its circulation time. Its structure includes several non-natural amino acid residues and a fatty acid side chain. These features distinguish it from earlier single-receptor incretin analogs studied in the same period.
The compound first appeared in the scientific literature as an investigational agent for type 2 diabetes. Clinical development proceeded through phase 1, phase 2, and phase 3 programs that measured glycemic control as a primary endpoint while recording body weight as a secondary outcome. Regulatory approval in the United States followed in 2022 for glycemic control, and a separate indication for chronic weight management was added later. Subsequent trials have examined cardiovascular outcomes in adults with elevated cardiovascular risk. Debates continue over how much of the observed effect derives from each receptor arm.
By the 1960s, Bryant Park had entered a state of deterioration, due to a lack of maintenance and its location in a business district with few nighttime activities. In an attempt to deter crime, new lighting was installed in Bryant Park in 1962. Nevertheless, in 1966, parks commissioner Thomas Hoving called a meeting to restore the park, noting its degraded condition. By the 1970s, Bryant Park had been taken over by drug dealers and the homeless, and was considered a no-go area by ordinary citizens and visitors. The condition of the park was so bad that in 1973, parks commissioner Richard M. Clurman threatened to "close Bryant Park and clear it of everybody—until we can get together and make it a place that New Yorkers want it to be." After a man was murdered at the park in 1976, the New York Times noted that gambling and drinking were commonplace at the park. In an opinion piece in the New York Daily News, Jerome Gartner, a coordinator for the Bryant Park Steering Committee, stated that the mugging of a Union Carbide executive in Bryant Park had been quoted as a reason for the company's moving out of New York City. An initial attempt at cleanup was commenced by the Bryant Park Community Fund in the mid-1970s. Free concerts were added in the hope that it would keep out criminals. The initiative was largely unsuccessful, though, and its funding was nearly depleted by 1977. Another initiative, the Bryant Park Steering Committee, was created in 1977 as a partnership between local businesses and the City University of New York.
=== Do–Du === George H. Dodd (c. 1942–2020). British biochemist who studied perfumes and pheromones. Edward Adelbert Doisy (1893–1986). American biochemist at St Louis University, known for discovering vitamin K. Nobel Prize in Physiology or Medicine (1943). Ford Doolittle (b. 1942). American biochemist at Dalhousie University, known for contributions to the study of cyanobacteria and of biochemical evolution in general. Member Natl. Acad. Sci. USA. Jonathan Dordick (b. 1959). American biochemical engineer at Rensselaer Polytechnic Institute, known for development of enzyme catalysis under extreme conditions. Ralph Dorfman (1911–1985). American biochemist at Stanford, known for treatments for cancer and rheumatoid arthritis Jennifer Doudna (b. 1964). American biochemist at UC Berkeley, known for CRISPR-mediated genome editing. Member Natl. Acad. Sci. USA. Nobel Prize in Chemistry, 2020. Alexander Dounce (1909–1997). American protein chemist at the University of Rochester, active in early work on the genetic code, one of the first to suggest that it was triplet-based. Gideon Dreyfuss (PhD 1978). American biochemist and biophysicist at the University of Pennsylvania, concerned with the function and biogenesis of non-coding RNA and the proteins that interact with RNA. Member Natl. Acad. Sci. USA. Jack Cecil Drummond FRS (1891–1952). British biochemist at University College London, known for the isolation of Vitamin A, and wartime advisor on nutrition. Murdered in France, with his wife and daughter. Vincent du Vigneaud (1901–1978).
== Definition of statistical coupling energy == Statistical coupling energy measures how a perturbation of amino acid distribution at one site in an MSA affects the amino acid distribution at another site. For example, consider a multiple sequence alignment with sites (or columns) a through z, where each site has some distribution of amino acids. At position i, 60% of the sequences have a valine and the remaining 40% of sequences have a leucine, at position j the distribution is 40% isoleucine, 40% histidine and 20% methionine, k has an average distribution (the 20 amino acids are present at roughly the same frequencies seen in all proteins), and l has 80% histidine, 20% valine. Since positions i, j and l have an amino acid distribution different from the mean distribution observed in all proteins, they are said to have some degree of conservation. In statistical coupling analysis, the conservation (ΔGstat) at each site (i) is defined as:
RNAi is an RNA-dependent gene silencing process that is controlled by RISC and is initiated by short double-stranded RNA molecules in a cell's cytoplasm, where they interact with the catalytic RISC component Argonaute. When the dsRNA is exogenous (coming from infection by a virus with an RNA genome or laboratory manipulations), the RNA is imported directly into the cytoplasm and cleaved to short fragments by Dicer. The initiating dsRNA can also be endogenous (originating in the cell), as in pre-microRNAs expressed from RNA-coding genes in the genome. The primary transcripts from such genes are first processed to form the characteristic stem-loop structure of pre-miRNA in the nucleus, then exported to the cytoplasm. Thus, the two dsRNA pathways, exogenous and endogenous, converge at the RISC. Exogenous dsRNA initiates RNAi by activating the ribonuclease protein Dicer, which binds and cleaves dsRNAs in plants, or short hairpin RNAs (shRNAs) in humans, to produce double-stranded fragments of 20–25 base pairs with a 2-nucleotide overhang at the 3′ end. Bioinformatics studies on the genomes of multiple organisms suggest this length maximizes target-gene specificity and minimizes non-specific effects. These short double-stranded fragments are called siRNAs. These siRNAs are then separated into single strands and integrated into an active RISC, by RISC-Loading Complex (RLC). RLC includes Dicer-2 and R2D2, and is crucial to unite Ago2 and RISC.
== External links == Histology image: 42_04 at the University of Oklahoma Health Sciences Center Histology image: 14302loa – Histology Learning System at Boston University Histology at KUMC endo-/endo10 Anatomy Atlases – Microscopic Anatomy, plate 15.287
Sources: en.wikipedia.org
Dom Pothier died at the old priory of Conques, Belgium in 1923; the Bishop of Luxembourg and six prelates attended his funeral at Clervaux abbey, Luxembourg (his remains later were transferred to Saint-Wandrille in 1962). The exiled community of St Wandrille's Abbey, under Dom Pothier as Abbot, founded in 1912 a new priory in Canada, Saint Benedict Abbey, Quebec, which later became independent within the Solesmes Congregation.
Bowfin are physostomes, meaning they have a small "pneumatic duct" that connects their swim bladders to their digestive tracts. This allows them, like lungfish, to "breathe" in two ways; they can extract oxygen from the water when breathing through their gills, but can also break the water's surface to breathe or gulp air through the pneumatic duct. When performing low-level physical activity, bowfin obtain more than half of their oxygen from breathing air. The fish have two distinct air-breathing mechanisms used to ventilate the gas bladder. Air-breathing type I is consistent with the action of exhale/inhale exchange, stimulated by either air or water hypoxia, to regulate O2 gas exchange; type II air breaths are inhalation alone, which is believed to regulate gas bladder volume to control buoyancy. Bimodal respiration helps bowfin survive and maintain their metabolic rate in hypoxic conditions. Bowfin breathe air more frequently when they are in darkness, and correspondingly more active. Bowfin blood can adapt to warm, acidic waters. The fish becomes inactive in waters below 10 °C (50 °F); at this temperature, they breathe almost no air, but with increasing temperature, their air breathing increases. Their preferred temperature range is between 12 and 26 °C (54 and 79 °F), with 18 °C (64 °F) the temperature of maximum activity. Air breathing is at a maximum in the range 18.4–29.6 °C (65.1–85.3 °F). Bowfin do not use central chemoreceptor regulation for respiration control.
I abolished feudalism and restored equality to all religion and before the law. I fought the decrepit monarchies of the Old Regime because the alternative was the destruction of all this. I purified the Revolution."
== In plants == As it does in human cells, glutathione reductase helps to protect plant cells from reactive oxygen species. In plants, reduced glutathione participates in the glutathione-ascorbate cycle in which reduced glutathione reduces dehydroascorbate, a reactive byproduct of the reduction of hydrogen peroxide. In particular, glutathione reductase contributes to plants' response to abiotic stress. The enzyme's activity has been shown to be modulated in response to metals, metalloids, salinity, drought, UV radiation and heat induced stress.
Sources: en.wikipedia.org
=== Secondary metabolites === Starfish produce a large number of secondary metabolites in the form of lipids, including steroidal derivatives of cholesterol, and fatty acid amides of sphingosine. The steroids are mostly saponins, known as asterosaponins, and their sulphated derivatives. They vary across species and are typically formed from up to six sugar molecules (usually glucose and galactose) connected by up to three glycosidic chains. Long-chain fatty acid amides of sphingosine occur frequently, with some having known biological activity. Starfish also contain various ceramides and a small number of alkaloids. These chemicals in the starfish may function in defence and communication. Some are feeding deterrents used by the starfish to discourage predation. Others are antifoulants and supplement the pedicellariae to prevent other organisms from settling on the starfish's aboral surface. Some are alarm pheromones and escape-eliciting chemicals, the release of which trigger responses in starfish of the same species, but often stimulate flight in potential prey. Research into the efficacy of these compounds for possible pharmacological or industrial use occurs worldwide.
The 12th congressional district shifted significantly in the 2020 United States redistricting cycle following the 2020 census: while it kept Dearborn, it lost Ann Arbor while gaining parts of Detroit. While prior to redistricting, Dingell lived in Dearborn, she chose to move to Ann Arbor and run in the new 6th district, which was drawn to contain Washtenaw County and Detroit suburbs in western Wayne County. This allowed Rashida Tlaib, who represented the old 13th district, to run in the new 12th district. Dingell faced no opposition in the Democratic primary. In the general election, she defeated Republican Whittney Williams with 65.9% of the vote.
Synthesis via the capping method relies strongly upon a thermodynamically driven template effect; that is, the "thread" is held within the "macrocycle" by non-covalent interactions, for example rotaxinations with cyclodextrin macrocycles involve exploitation of the hydrophobic effect. This dynamic complex or pseudorotaxane is then converted to the rotaxane by reacting the ends of the threaded guest with large groups, preventing disassociation.
== Research and Impact == Bhatia leverages miniaturization tools drawn from the computer industry to drive medical innovation. Her groundbreaking work has broad applications in cancer, liver, and infectious diseases, leading to significant advancements in early disease detection, human disease modeling, tissue regeneration, cell transplantation, and the development of cancer therapeutics. Bhatia's laboratory, the Laboratory for Multiscale Regenerative Technologies (LMRT), operates at the interface of living and synthetic systems, engineering micro and nanotechnologies to tackle complex human health challenges.
Protein phosphorylation is a reversible post-translational modification of proteins in which an amino acid residue is phosphorylated by a protein kinase by the addition of a covalently bound phosphate group. Phosphorylation alters the structural conformation of a protein, causing it to become activated, deactivated, or otherwise modifying its function. Approximately 13,000 human proteins have sites that are phosphorylated. The reverse reaction of phosphorylation is called dephosphorylation, and is catalyzed by protein phosphatases. Protein kinases and phosphatases work independently and in a balance to regulate the function of proteins. The amino acids most commonly phosphorylated are serine, threonine, tyrosine, and histidine. These phosphorylations play important and well-characterized roles in signaling pathways and metabolism. However, other amino acids can also be phosphorylated post-translationally, including arginine, lysine, aspartic acid, glutamic acid and cysteine, and these phosphorylated amino acids have been identified to be present in human cell extracts and fixed human cells using a combination of antibody-based analysis (for pHis) and mass spectrometry (for all other amino acids). Protein phosphorylation was first reported in 1906 by Phoebus Levene at the Rockefeller Institute for Medical Research with the discovery of phosphorylated vitellin. However, it was nearly 50 years until the enzymatic phosphorylation of proteins by protein kinases was discovered.
Sources: en.wikipedia.org
It acts as a dual agonist at the GIP receptor and the GLP-1 receptor. This broader targeting profile distinguishes it from selective GLP-1 agonists, which engage only one receptor.
A fatty diacid side chain promotes binding to albumin, which delays clearance from circulation. The half-life of roughly five days makes a weekly schedule practical.
No. It is a synthetic peptide whose backbone is based on the natural incretin hormone GIP. Non-natural residues and the lipid side chain were engineered to improve stability and duration of action.
It is a synthetic peptide that activates both the GIP and GLP-1 receptors, making it a dual agonist. Approved products are given by injection rather than by mouth. It is not a small molecule and does not belong to the older sulfonylurea or thiazolidinedione families.